 |
Corporate News
02-Mar-23
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals allots 4,762 equity shares under ESOS
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has allotted 4,762 equity shares under ESOS. Consequently, the issued, subscribed and paid up capital has increased from 7,73,72,822 equity shares of Rs. 2 each to 7,73,77,584 equity shares of Rs. 2 each
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals consolidated net profit rises 35.50% in the June 2023 quarter
(
Results
-
Announcements
09-Aug-23
17:30
)
|
|
|
J B Chemicals & Pharmaceuticals to hold AGM
(
Corporate News
-
05-Jul-24
09:53
)
|
|
|
J.B.Chemicals inks pact with Novartis
(
Hot Pursuit
-
19-Dec-23
15:21
)
|
|
|
J B Chemicals & Pharmaceuticals board approves execution of trade mark license agreement with Novarits Therapies AG
(
Corporate News
-
19-Dec-23
13:34
)
|
|
|
J B Chemicals & Pharmaceuticals fixes record date for stock split
(
Market Beat
-
Reports
29-Aug-23
11:36
)
|
|
|
J B Chemicals & Pharmaceuticals to discuss results
(
Corporate News
-
31-Jan-24
12:42
)
|
|
|
J B Chemicals & Pharmaceuticals CFO resigns
(
Corporate News
-
07-Sep-23
18:22
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 32.42% in the September 2021 quarter
(
Results
-
Announcements
13-Nov-21
09:39
)
|
|
|
J B Chemicals & Pharmaceuticals schedules board meeting
(
Corporate News
-
19-Jul-19
17:19
)
|
|
|
JB Pharma to acquire Razel franchise from Glenmark Pharma for Rs 314 cr
(
Hot Pursuit
-
15-Dec-22
11:36
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 91.21% in the March 2019 quarter
(
Results
-
Announcements
22-May-19
15:07
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|